| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 10.3% | 1.2% | 9.9% |
Roubaix Capital's small cap long/short strategy generated +1.2% net returns in Q4 2025, bringing full-year 2025 returns to +9.9%. The fund maintains average net exposure of 47% while focusing on structural inefficiencies in smaller company markets that create alpha generation opportunities. Key contributors included SiTime Corp, benefiting from AI data center demand for precision timing solutions, and ATI, capitalizing on aerospace industry capacity shortages driving sustained pricing power. The portfolio emphasizes 'picks and shovels' businesses with recurring revenue models and high switching costs. Looking ahead, the manager sees a benign economic outlook supported by continued monetary easing and fiscal stimulus. Small caps are positioned to outperform large caps in 2026 after an extended period of underperformance. The AI investment cycle continues to drive productivity gains across the economy. Key risks include policy uncertainty, geopolitical tensions, and elevated valuations in mega-cap technology. The strategy remains focused on identifying differentiated opportunities through disciplined fundamental research across 30-50 long and short positions.
Small cap long/short equity strategy focused on identifying mispriced opportunities in structurally inefficient smaller company markets through disciplined fundamental research and stock selection.
The solid economic expansion reflected in 2025 GDP growth provides a strong starting point for 2026. The overall outlook is benign with monetary and fiscal policy expected to be supportive. The economy is expected to broaden out in its recovery, with small caps positioned to end their long period of underperformance relative to large caps.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jan 28 2026 | 2025 Q4 | ATI, EAT, GTLB, INOD, KTB, META, MSFT, PDFS, RVTY, SEAT, SITM, STUB, TKNO | AI, alpha, healthcare, Long/Short, semiconductors, small caps, value | - | Small cap long/short fund delivered +9.9% in 2025 through disciplined stock selection in structurally inefficient markets. Strong contributors from AI-beneficiary SiTime and aerospace materials provider ATI. Outlook remains constructive with monetary and fiscal tailwinds supporting small cap outperformance in 2026. Strategy focuses on mispriced opportunities with recurring revenue models and competitive moats while managing risks through balanced long/short positioning. |
| Nov 11 2025 | 2025 Q3 | AGYS, BRBR, GDYN, JACK, KLG, PKE, RAL, TATT, TRNS | aerospace, AI, defense, healthcare, Long/Short, small caps, technology | TATT | Strong Q3 performance driven by aerospace and defense investments amid structural market opportunities in small caps. Manager sees favorable setup for 2026 with Fed easing, AI productivity gains, and broadening earnings recovery. Key risks include trade tensions and job market softening. Increased healthcare exposure while shorting consumer companies vulnerable to changing preferences and GLP-1 disruption. |
| Aug 19 2025 | 2025 Q2 | AGYS, AZTA, BIO, EXPO, FTAI, HELE, KRMN, LASR, MGNI, PACK, SPHR, TATT, TKNO | aerospace, AI, Biotechnology, defense, Long/Short, Rate Cuts, small caps, tariffs | - | Strong Q2 recovery with +9.6% returns driven by broad-based long book success, particularly in digital advertising and hospitality software. Fund maintains aerospace and defense focus while increasing healthcare exposure. Constructive outlook supported by pro-business fiscal policies, expected rate cuts, and improving small cap fundamentals after years of cyclical headwinds. |
| Apr 24 2025 | 2025 Q1 | AMSC, COLD, FLYW, FTRE, HELE, KRMN, KRNT, LH, MTLS, NSIT, PAYX, PYRC, RGEN, RHP, SARO, TLN, TRS, XMTR | Biotechnology, defense, energy, Long/Short, Onshoring, small caps, tariffs, Trade Policy | - | Fund returned -9.7% in Q1 as aggressive tariff policy derailed small cap recovery thesis, with policy uncertainty reaching crisis levels. Portfolio positioned for cyclical improvement was hurt by sector rotation and individual stock selection. Manager adjusted risk profile while maintaining focus on structural inefficiencies in small caps, expecting volatility to create opportunities despite macro headwinds from trade disruption. |
| Dec 31 2024 | 2024 Q4 | ALGM, BE, BELFB, BIRK, CCB, ENS, FTAI, KNF, MIR, NCNO, ORION, PACK, PKX, PRTY, RGLD, SRAD, STAA, TALEN, TEKK | healthcare, industrials, Long/Short, mid cap, small cap, technology | - | Stars & Stripes outperformed Russell 2000 in December through strong short positioning despite long book weakness. The fund maintains 46% net exposure in US mid/small caps, benefiting from healthcare shorts and select consumer positions while facing headwinds in industrials and technology holdings amid shifting Fed rate expectations. |
| Nov 7 2024 | 2024 Q3 | BIO, BLFS, CRS, DOCS, FLT, FND, FOXF, NR, PCT, RGEN, SHC, UPWK, WEX | aerospace, healthcare, infrastructure, interest rates, Long/Short, Recession, semiconductors, small cap | - | Small cap long/short fund outperformed in volatile Q3, delivering -2.0% versus Russell 2000's -5.1% decline. Strong performance from aerospace and infrastructure holdings, successful short exits. Economic resilience continues but faces headwinds from persistent inflation, global weakness, and geopolitical tensions. Portfolio positioned to capitalize on rolling industry cycles and small cap inefficiencies while maintaining disciplined risk management. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
AIAI investment cycle continues driving economic growth and market gains. Revenue per employee increasing at large AI companies supports the investment thesis. AI spend levels comparable to past tech investment expansions. |
Artificial Intelligence Data Centers Investment Cycle Productivity Technology |
Small CapsSmall caps expected to grow at better pace than large caps in 2026. Long period of underperformance relative to large caps may end with better profit growth. Strong start to 2026 supported by easing monetary conditions. |
Russell 2000 Underperformance Profit Growth Valuation Recovery | |
SemiconductorsSemiconductor industry experiencing high growth from normal demand and AI buildout. PDF Solutions positioned at nexus of strong industry trends with e-probe business seeing order pickup for 3-D semiconductor structures. |
Chip Demand 3D Structures Supply Chain Yields Growth | |
HealthcareHealthcare positioned for catch-up growth after years of below-trend performance. Government spending expected to increase relative to feared cuts. Many companies signaling improvement in revenue growth outlook. |
Life Sciences Research Spending Recovery Growth Diagnostics | |
RatesFed lowered overnight rate by 25 basis points in December, third cut in 2025. Futures market anticipates one or two more cuts in 2026. Three cuts in 2025 likely to be added to in 2026 as monetary policy tailwind. |
Federal Reserve Rate Cuts Monetary Policy Easing Tailwind | |
| 2025 Q3 |
AerospaceThe fund sees significant opportunities in aerospace companies, particularly those benefiting from maintenance cycles and growth in auxiliary power units. TAT Technologies is positioned to capture market share in the B737 and A320 family aircraft markets with a total addressable market of $2.5 billion. |
MRO APU Aircraft Defense OEM |
Defense SpendingDefense-related investments are benefiting from increased procurement needs, particularly in missile systems. Park Aerospace has exposure to Patriot missile systems where the US Army is looking to increase procurement by 4x from current depleted levels. |
Patriot Missiles Military Procurement Defense | |
AIAI is viewed as a major productivity driver that has contributed approximately 1% to GDP growth. The manager expects AI investments to lead to improved labor productivity and margin expansion, though acknowledges the full benefits are yet to be realized. |
Productivity GDP Automation Technology Margins | |
Small CapsThe manager believes small caps remain attractive with supportive valuations and improving earnings outlook for 2026. Historical cycles suggest extended periods of relative outperformance when trends shift, supported by monetary easing and broadening earnings growth. |
Valuations Earnings Outperformance Cycles Monetary | |
GLP1GLP-1 weight loss medications are disrupting traditional food and beverage consumption patterns, reducing average calorie intake by 16-39%. This creates challenges for legacy food companies and restaurants while creating opportunities for protein-focused businesses. |
Weight Loss Consumption Food Disruption Protein | |
| 2025 Q2 |
DefenseDefense spending has strengthened with clearer priorities, particularly in missile and drone defense reflecting modern warfare evolution. The fund identified nLIGHT as a beneficiary of increased spending on laser-based anti-missile and anti-drone systems, which offer cost-efficient solutions with low cost per shot and unlimited magazine capacity. |
Defense Spending Laser Technology Missile Defense Drone Defense Golden Dome |
AerospaceThe fund consistently invests in aerospace given its steady growth, attractive margins for value-added suppliers, regulatory barriers to entry, and emphasis on quality. Recent investments include TAT Technologies for MRO services in commercial aerospace, capitalizing on growing demand while incumbents hesitate to expand capacity. |
MRO Commercial Aviation Auxiliary Power Units Aerospace Components Aviation Services | |
BiotechnologyBioprocessing is entering a period of sustained recovery after years of underperformance. The fund increased exposure through positions like Bio-Rad Laboratories and Alpha Teknova, believing many headwinds are now reflected in valuations and the sector is positioned for recovery. |
Bioprocessing Life Science Tools Drug Development Commercial Stage Sartorius | |
AIAI presents both opportunities and threats across sectors. While large companies benefit from AI spending boom accounting for up to half of GDP growth, AI also creates disruption risks for consulting firms through systematic reference capabilities and increased time efficiency in background work. |
Artificial Intelligence AI Spending Expert Consulting Automation Efficiency | |
AdvertisingDigital advertising is experiencing a long tail transition from linear to streaming TV. Magnite, as the leading independent supply-side platform, benefits from this shift and potential DOJ antitrust remedies against Google, which could increase market share opportunities significantly. |
Digital Advertising Connected TV Supply Side Platform Streaming Antitrust | |
Trade PolicyTariff shock on Liberation Day created unprecedented uncertainty with rates so high the situation escalated from trade war to trade embargo. The ever-changing tariff narrative continues to yield surprises, though effects on businesses have been limited as companies proactively factor costs into outlooks. |
Tariffs Trade War Trade Embargo Economic Uncertainty Business Impact | |
| 2025 Q1 |
Trade PolicyThe administration announced tariff rates far higher than anticipated on April 2nd, reverting the U.S. to protectionist policies not seen for 100 years. Policy uncertainty measures shot to near record highs, creating large negative impacts on stock, bond and currency markets. Businesses face increased costs from higher tariffs and supply chain adjustments. |
Tariffs Protectionism Supply Chain Policy Uncertainty Trade War |
Small CapsSmall caps significantly underperformed large caps during the quarter, entering a bear market with a peak-to-trough decline just shy of 30%. The fund believes small caps had a better opportunity to improve relative to the market due to cyclical recovery expectations and sustained underperformance. |
Russell 2000 Underperformance Bear Market Cyclical Recovery Valuation | |
DefenseThe fund has invested in several defense stocks that will benefit from stability in overall defense spending and shifting priorities that emphasize the navy and modernizing weapon systems. Examples include Karman Holdings which supplies subsystems for space, missiles, and hypersonic weapons. |
Defense Spending Modernization Space Missiles Navy | |
OnshoringOne goal of trade policy is to onshore manufacturing of key goods. Investment announcements have been made to produce more goods in the U.S., though the investment needed will take years to have impact and require skilled workforce. Companies like Xometry and Kornit Digital benefit from localized production trends. |
Manufacturing Domestic Production Supply Chain Localization Investment | |
Energy TransitionTalen Energy's crown jewel Susquehanna nuclear power plant signed a long-term power purchase agreement with Amazon Web Services for 960 MW. Given demand for clean energy and AI datacenters, nuclear assets have scarcity value in the PJM market with limited new generation capacity expected by 2030. |
Nuclear Clean Energy Data Centers Power Purchase Agreement Grid Capacity | |
BiotechnologyThe life science tools industry experienced headwinds from post-COVID de-stocking but shows green shoots with Repligen's pharma and consumable orders increasing mid-to-high teens. Near-record 64 new drug approvals in 2024 suggest the post-COVID hangover is ending. |
Life Science Tools Drug Development Bioprocessing Post-COVID Recovery FDA Approvals | |
| 2024 Q3 |
SemiconductorsThe semiconductor industry has experienced a 20%+ decline in revenues similar to past industry cycles, following supply shortages that drove demand to unsustainably high levels during the pandemic. The manager sees opportunities in this rolling cycle as the industry normalizes from previous boom-bust dynamics. |
Semiconductor Cycle Supply Chain Cyclical Recovery Industry Normalization Revenue Decline |
AerospaceCommercial aerospace benefits from barriers to entry created by regulation, long production cycles and high switching costs, enabling value-added suppliers to earn high margins. The industry faces a long duration expansion cycle due to high travel demand and unusual supply depression during recent years. |
Commercial Aviation Supply Chain Barriers to Entry Travel Demand Production Cycles | |
Infrastructure SpendingU.S. infrastructure spending is rising, creating high demand for composite mats and related services. The manager expects this trend to continue, supporting companies that provide infrastructure-related products and services with positive operating leverage. |
Infrastructure Government Spending Composite Materials Construction Operating Leverage | |
BiotechnologyHealthcare sector growth is supported by aging population and improving treatment options, but faces pressure from higher interest rates affecting funding and broad inventory destocking. The pandemic encouraged aggressive spending that continues to normalize, creating opportunities as conditions improve. |
Healthcare Aging Demographics Medical Devices Funding Pressure Inventory Destocking |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Fund Letters | Christopher Hillary | TATT | TAT Technologies Ltd. | Industrials | Aerospace & Defense | Bull | NASDAQ | Aerospace, aftermarket, Apus, Defense, growth, MRO, valuation | Login |
| TICKER | COMMENTARY |
|---|---|
| ATI | ATI (ATI) was the second largest contributor to our long book during the fourth quarter. ATI primarily produces highly differentiated specialty materials for regulated industries with long lead times and higher barriers to entry such as Aerospace & Defense ("A&D") and medical. Historically, we have had success identifying unique aerospace companies, which have seen incredibly consistent passenger growth over the last ten and twenty years at 5-6% and 4-5%, respectively. ATI derives 86% of its revenues from the aerospace & defense industry, including 62% from the higher value commercial jet engine market. Currently, the industry is experiencing a shortage of engine capacity leading to sustained multi-year pricing power for producers like ATI. To put this in perspective, in Q3 2025 the company reported adjusted EBITDA margins of 20% compared to 13.7% three years ago. The A&D sector is characterized by long-life platforms, as commercial jet engines generally last for multiple decades and have regular, highly regulated maintenance schedules. We believe these dynamics translate into highly visible revenue growth for ATI, and the ability to optimize their operational processes to drive incremental margins. We believe ATI is one of only a handful of global companies capable of supplying aerospace and defense-grade materials that are the building blocks to manufacture airframes, engines, missiles and even parts for nuclear and space programs. The stock has seen a significant positive re-rating as the critical products that it delivers to customers have increased margins by 700 basis points in the last three years. We exited the position as the valuation approached our internally estimated fair-value range. |
| EAT | Brinker International (EAT) was the largest detractor in our short book during the fourth quarter. Brinker's flagship restaurant concept, Chili's Grill & Bar, accounts for 90% of company's sales and operating profits. Chili's is a fifty-year-old restaurant banner whose restaurant count of approximately 1,600 units is roughly the same as ten years ago. A leader in the fragmented and low barrier to entry casual dining industry, the concept is seen as mature with average same-store sales growth of 0.3% between 2010 and 2019 and restaurant-level margins ("RLM") of 13% or lower during the 2010s. Then from fiscal Q4 2024 through fiscal Q1 2026, Chili's same-store sales jumped 14.8%, 14.1%, 31.4%, 31.6%, 23.7%, and 21.4%. This unusually rapid revenue growth created significant operating leverage, with RLMs reaching the high teens. Our experience tells us this level of operating improvement for a mature brand in a crowded industry with low barriers and limited long-term consumer loyalty is unsustainable. We were skeptical that a fifty-year brand with little unit or same-store sales growth over a decade could sustainably change its stripes. We believed Brinker had used all its levers to grow, yet they appear to continue to operate at a high level. Although we covered the position, our process is designed to monitor past names to look for potential reentry points. |
| GTLB | We identified GitLab (GTLB) as a short opportunity based on structural and competitive risks to its business model. GitLab provides a Development, Security, and Operations platform designed to help organizations build, secure, and deploy software across the development lifecycle. The company monetizes its platform through a subscription model primarily priced on the number of developer "seats" at each customer. We believe this model is increasingly vulnerable as advances in Generative Artificial Intelligence reshape how software is developed. Over the past several years, GenAI has emerged as one of the defining investment themes, driving significant investment in AI infrastructure and spurring rapid innovation in AI‑enabled coding tools such as Claude Code, Cursor, and Windsurf. These tools have expanded developers' productivity and, in some cases, reduced the amount of manual coding required, raising questions about long‑term demand for traditional seat‑based pricing models. In addition, GitLab's unified platform faces growing competitive pressure from AI‑native point solutions as enterprises increasingly favor best‑of‑breed tools rather than bundled offerings. Competitive intensity is further heightened by GitHub, owned by Microsoft, which continues to benefit from Microsoft's substantial distribution advantages and has increasingly become a widely adopted platform for developers. Recent operating trends have reinforced these concerns, with net customer additions at higher spending tiers, slowing meaningfully compared to the prior year. Taken together, we believe these dynamics increase the risk of revenue growth underperformance and valuation pressure should expectations fail to be met. |
| INOD | Innodata (INOD) was the second largest contributor to our short book during the fourth quarter. Innodata is an AI service company, meaning it relies on human capital for data annotation, validation and AI safety work that its customers would rather not perform themselves. The company has a long history with several pivots with its business model over the years. Initially, in 1988, Innodata helped convert information products from print to digital for distribution on the internet. Fast forward to today and Innodata finds itself in the "right place, right time," according to one sell side firm, to deliver AI data preparation to Large Language Model providers such as OpenAI. This is not high value as illustrated by Innodata's gross margins in the low 40% range. We were skeptical that the company had carved out a sustainable moat, particularly as private competitors have attracted significant capital at high valuations, which underscores the competitive intensity of the space. Innodata also has notable customer concentration with its largest customer making up a significant portion of consolidated sales. This customer is believed to be META, who made a $14 billion investment in ScaleAI, a rival to Innodata, which further raises concerns about the value of Innodata's services. Moreover, it does not help that the company's customer service terms allow for 30-to-90-day cancellation of projects, leading to lower revenue visibility which we believe could easily come in below expectations. For these reasons, we shorted the stock given our conviction that Innodata may be competitively disadvantaged as AI workflows evolve, accepting the contrarian view that a rising AI tide could lift all boats. Our timing was fortuitous, and we covered our position shortly after the start of the New Year. |
| KTB | We identified Kontoor Brands (KTB) as a short opportunity following notable turnover within the company's leadership team. The departures of the EVP and COO came on the heels of a surprise CEO transition related to the acquisition of Helly Hansen. While some degree of management turnover is to be expected, we believe multiple senior departures occurring in close succession can signal underlying business challenges. We also view certain mergers and acquisitions as potential indicators that a company's core business may be under pressure. In our assessment, Kontoor paid a meaningful premium for the Helly Hansen acquisition, which we believe increases the risk that the transaction could ultimately prove value‑destructive. In addition, we believe industry data and brand‑level trends point to rising competitive pressures across Kontoor's portfolio. Taken together, we believe these factors increase the possibility of disappointing operating results and create risk that the stock could rerate lower should fundamentals continue to deteriorate. |
| META | On January 9, Meta Platforms unveiled a new agreement with Vistra—the largest generator of competitive electricity in the United States—as well as with TerraPower and Oklo. The announcement builds on Meta's agreement last year with Constellation Energy and positions the company to become one of the largest corporate purchasers of nuclear-generated electricity in the United States. |
| MSFT | MSFT was a detractor in 4Q25 following its fiscal first-quarter 2026 earnings report released on October 29. While results were better than expected operationally, investor reaction was driven by guidance and capital expenditure intensity rather than headline performance. Revenue grew 17% year-over-year, exceeding consensus expectations, and Azure revenue increased 39% year-over-year, also ahead of estimates. However, management guided to a sequential deceleration in Azure growth in fiscal Q2, signaling some moderation after a period of exceptional demand. |
| PDFS | PDF Solutions (PDFS) sits at the nexus of several strong industry trends, and the company outlined its vision for the future in December 2025. The semiconductor industry is undergoing high growth as it meets normal demand and the demand from the AI buildout. The company's e-probe business is seeing orders pick up for this tool that enables higher yields in rapidly growing 3-D semiconductor structures. The company's Exensio business acts at a neutral database enabling the multiple layers and steps in the supply chain to share information and continuously work towards improved yields. With the U.S. building out a denser network of semiconductor supply chains across the country, we believe the need for PDFS's solutions is increasing. As companies build out multiple supply chains, we believe the need to cooperate and share data is rising and that this increases the value proposition for PDFS. The company expects revenues to grow at or above 20% and to deliver operating margins in the high 20s. We believe these financial factors and being in the middle of two key industry trends could support meaningful valuation expansion over time. |
| RVTY | Revvity (RVTY) has undergone a series of corporate changes and, in our view, is effectively a "new company with a new name" for most investors. Today, we believe Revvity's portfolio mix is significantly improved, with approximately half of revenues derived from diagnostics and half from life sciences. More than 80% of revenue is recurring, and the company benefits from generally high switching costs across its end markets. Following several years of subpar growth, Revvity expects low single‑digit revenue growth in 2026, with longer‑term revenues anticipated to trend toward mid‑ to high‑single‑digit growth. We believe this revenue acceleration has the potential to drive margin expansion from the high‑20% range toward the mid‑30s over time and may support the emergence of a "beat and raise" narrative as the recovery unfolds. |
| SITM | SiTime Corp (SITM) was the largest contributor to our long book during the fourth quarter. SiTime is the leading provider of precision timing solutions to the global electronics industry. Personal electronics including your phone, computer, and car require extremely precise clocks to keep everything in sync. So too, do AI data centers. Traditionally, companies used quartz crystals, however, Micro-Electro-Mechanical System oscillators, like the ones SiTime produces, are smaller, more precise, and easier to program. SiTime is a leading provider with a primary focus on precision timing applications. Although the total addressable market is relatively small ($4.5 billion oscillators, $4.5 billion resonators, and $2 billion clocks with $315 million in estimated FY 2025 revenues), we believe SiTime has excellent growth potential. We believe CEO Rajesh Vashist's execution has been strong, and the company's Communications, Enterprise and Datacenter ("CED") segment sales grew 115% year-over-year in Q3 2025. This is the sixth consecutive quarter of triple-digit growth in CED, a segment that represents slightly more than 50% of consolidated sales. In a response to a question on the Q3 call regarding the sustainability of growth from the data center ecosystem, Rajesh said, "we are in the early innings … we're selling to semiconductor companies, hyperscalers, OEMs, ODMs, module makers and active cable makers. SiTime has an embarrassment of riches." While we are bullish on SITM's prospects, its recent appreciation took the stock to a valuation where we no longer saw material upside, and we exited the position. |
| STUB | StubHub Holdings (STUB) was the largest contributor to our short book during the fourth quarter. StubHub operates one of the largest global secondary ticketing marketplaces for live events. The marketplace connects fans (consumers) with ticket resellers. StubHub went public in September 2025 and our work on public competitor Vivid Seats (SEAT) informed us of our decision to short StubHub. In our view, StubHub sells a commoditized product available to other reseller networks, which is very difficult to differentiate versus its peers. Consumers are also infrequent purchasers of live events, which creates high acquisition costs and low loyalty to any one marketplace. Finally, the pricing (primarily high service fees) creates a negative consumer experience. As we analyzed the financials, we believed the company was effectively trying to buy growth since sales in FY 2025 grew 29%, yet sales and marketing grew 60%, a strategy potentially seeking to drive a higher valuation at its IPO. As the valuation was more than double its nearest competitor, we saw an opportunity to short the stock given low switching costs, intense competition, and uncertain future fundamentals. StubHub failed to provide guidance on its Q3 2025 call, and investors sold the stock aggressively. We closed the position following the post-earnings move. |
| TKNO | Alpha Teknova (TKNO) was the largest detractor in our long book during the fourth quarter. Alpha Teknova is a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. One of our favorite archetypes is companies that make the 'picks & shovels' of their industry. Alpha Teknova doesn't invent new medicines or vaccines, but it provides the tools like reagents and lab supplies for over 3,000 biotech customers to grow cells, mix chemical reactions, and run experiments. We believe the beauty of its business model is that Alpha Teknova's products generate recurring revenues with high switching costs since customers do not want to refile technical paperwork with the FDA on their drug development programs. Unfortunately, the company has faced macro headwinds, including a multi-year pandemic hangover, a poor biotech funding environment, and concerns about government and academic spending priorities, all of which have caused customer caution. Based on our analysis, we believe Alpha Teknova's recurring revenue model and end‑market positioning offer compelling upside potential as industry conditions normalize. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||
